On September 16, the fifth China Quality Award winners were officially announced, with China Feihe Dairy earning the China Quality Award Nomination for its "Dual-Chain Integration of Industry and Innovation Smart Manufacturing Quality Management Model." This makes Feihe the only infant formula company to receive this prestigious honor.
This recognition represents both a significant endorsement of Feihe's 63-year commitment to quality excellence and an important milestone in the advancement of China's dairy industry quality management standards. The award acknowledges Feihe's sustained dedication to high-quality development and serves as compelling evidence of the broader improvements achieved across China's dairy sector. Industry experts suggest that Feihe's innovative quality management approach not only establishes a benchmark for the dairy industry but also offers valuable reference points for advancing high-quality manufacturing throughout China.
63 Years of Safety Excellence Earns Top Industry Recognition
Behind this prestigious award lies Feihe's vital mission to safeguard the nutritional security of Chinese infants. As an infant formula manufacturer, Feihe understands that every can of formula directly impacts the healthy development of the next generation, treating product quality as the company's lifeline. Since its founding in 1962, Feihe has upheld the core principle that "quality yields to nothing," implementing its "Three Never Compromise" quality commitments—quality never yields to cost, quality never yields to production volume, and quality never yields to authority—resulting in an impeccable 63-year record of zero safety incidents.
Since 2006, Feihe has developed an integrated industrial cluster along the prime dairy belt at latitude 47°N, encompassing pasture cultivation, feed processing, large-scale farming, production processing, and logistics warehousing. This comprehensive approach ensures end-to-end autonomous control from source to shelf, providing a solid foundation for product quality and safety.
Regarding milk source safety, raw milk from Feihe's dedicated pastures maintains bacterial colony counts that are 20 times superior to EU standards and 400 times better than national requirements, ensuring premium quality from the very beginning. The company's pioneering "2-Hour Ecosystem" further exemplifies its commitment to exceptional product quality. Fresh milk is rapidly cooled to 0-4°C immediately after milking and transported through a fully sealed cold chain to production facilities within 2 hours, maximizing the retention of bioactive nutrients in the fresh milk.
Leading National Breast Milk Research During the 14th Five-Year Plan Period
As a leader in China's dairy industry, Feihe has innovatively established its "Dual-Chain Integration of Industry and Innovation Smart Manufacturing Quality Management Model," combining comprehensive industry chain development with technological innovation to create an industry-leading quality management system. This approach's advantages extend beyond Feihe's pioneering "agriculture-pastoral-industry" integrated model to encompass the entire process from R&D processes and quality control to smart manufacturing and service experience, establishing new standards for high-quality development in both the dairy and food industries.
To develop formula better suited to Chinese infants, Feihe has conducted extensive research into Chinese breast milk, achieving a series of breakthrough results. As the lead organization for a national key R&D program during the 14th Five-Year Plan period, Feihe and its partner universities and institutions have collected breast milk samples from 10 dietary culture regions nationwide, established the country's largest maternal and infant health cohort, created China's first comprehensive HMOs structural database, and developed the first proprietary breast milk intelligence engine. These efforts have enabled in-depth study of Chinese breast milk composition and variation patterns, laying a solid foundation for developing next-generation infant formula specifically designed for Chinese babies and positioning China's independent innovation capabilities in infant formula at the forefront internationally.
According to company information, some of Feihe's breast milk research findings have already been incorporated into product lines. For instance, all Feihe infant formula products, including Xingfeifan and Xingfeifan Zhuorui, innovatively utilize a 1:1.7 golden ratio of DHA to ARA, with Zhuorui formula achieving human milk-equivalent levels of highly active N-glycans, all made possible through the company's intensive scientific research.
While advancing technological innovation, Feihe has established a rigorous quality assurance system. On the production side, the company strictly adheres to pharmaceutical-grade Class 100,000 cleanroom standards, with workshop cleanliness comparable to hospital ICUs. For testing, Feihe pioneered flow cytometry in the industry, completing equipment cleanliness assessments within 30 seconds compared to the traditional 2-3 day process, dramatically improving detection efficiency and accuracy. The company has also innovatively introduced AIB International food safety preventive control standards audits, utilizing unannounced inspections to ensure quality standards are maintained. Currently, Feihe has established 1,322 quality management protocols covering agricultural management, R&D technology, and laboratory management, implementing 24-hour comprehensive testing across 25 testing procedures and 411 individual test parameters.
AI applications have further strengthened Feihe's quality foundation. As one of the first dairy companies to embrace AI, Feihe has built a digital-intelligent production management system to achieve smart manufacturing upgrades. Its proprietary AI Smart Vision system represents the world's first millisecond-level online monitoring of the entire infant formula production process, transforming dairy testing from sample-based inspection to continuous full-time monitoring. Digital intelligence has also significantly enhanced Feihe's supply chain efficiency, improving overall supply chain performance by 40% and ensuring products reach consumers fresh within 28 days.
Market and Industry Recognition for Next-Generation Fresh Nutrition Leadership
This commitment to quality has earned Feihe strong consumer loyalty and solidified its market leadership position. According to Frost & Sullivan statistics, Feihe has ranked first in China's infant formula market sales for six consecutive years and first globally in infant formula sales for four consecutive years. In the first half of 2025, Feihe maintained its number one position in both market share and sales volume across all channels in China's infant formula market. Regarding brand influence, authoritative research data shows that in Q2 2025, Feihe achieved 99% brand awareness, firmly securing the top position in consumer mindshare.
Alongside market recognition, Feihe's product quality has received high praise from both domestic and international authoritative institutions. Beyond winning the World Quality Selections Gold Award for eight consecutive years and the globally renowned TPM Award for manufacturing excellence three times—often called the "Nobel Prize" of manufacturing—Feihe has also received the "People's Craftsmanship Award," been named a "National Technology Innovation Demonstration Enterprise," selected for the "Brand Powerhouse Project," and earned the "ROI-EFESO Industry 4.0 China Award" among numerous other significant honors.
High-quality development requires technological innovation. Focusing on "fresh nutrition," Feihe has built an industrial ecosystem centered on its 2-hour ecosystem as the foundation for freshness and Chinese breast milk as the gold standard for product development. This creates a closed loop of "research-driven innovation, product application, and evidence-based advancement," delivering fresh nutrition directly from premium milk sources to Chinese infants' bottles. Through its "Next-Generation Fresh Nutrition" core technology innovations, Feihe has broken from traditional technical approaches by directly extracting targeted bioactive nutrients from high-quality fresh milk produced at latitude 47°N using low-temperature processes, enabling formula to retain maximum natural active nutrition from fresh milk for easier infant absorption.
Research reports from Feihe's collaborations with multiple prestigious universities and institutions demonstrate that Xingfeifan Zhuorui achieves 2x nutritional activity, 6.4x better absorption, and 3.9x promotion of brain neuron development, among other evidence-backed benefits. Feihe's "Next-Generation Fresh Nutrition" research and industrial practice achievements span the complete chain of fresh milk sources, freshness technology, fresh nutrition products, and scientific validation, providing valuable experience for industry-wide high-quality development.
Looking ahead, Feihe will continue to uphold its quality commitment, driven by technological innovation, continuously improving and upgrading its quality management systems to lead industry-wide high-quality development, provide consumers with superior products and services, help China's dairy industry reach world-leading standards, and contribute to the national strategy of building a quality powerhouse.
Comments